Cargando…
Generation of high cross-presentation ability human dendritic cells by combination of interleukin 4, interferon β and GM-CSF
Dendritic cell (DC)-based immunotherapies have been utilized for the treatment of numerous diseases. However, the conventional generation strategies of DCs in vitro require 7 days and these DCs showed an unsatisfactory function, which prompted us to explore new approaches. We found that in vitro cul...
Autores principales: | Pi, Yihua, Li, Yifang, Liang, Rongyi, Xiao, Jian, Leng, Jing, Zhang, Lifeng |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9894086/ https://www.ncbi.nlm.nih.gov/pubmed/36751394 http://dx.doi.org/10.5114/ceji.2022.117767 |
Ejemplares similares
-
Glutamine Deprivation Promotes the Generation and Mobilization of MDSCs by Enhancing Expression of G-CSF and GM-CSF
por: Sun, Hong-Wei, et al.
Publicado: (2021) -
GM-CSF Monocyte-Derived Cells and Langerhans Cells As Part of the Dendritic Cell Family
por: Lutz, Manfred B., et al.
Publicado: (2017) -
Recombinant GM-CSF for diseases of GM-CSF insufficiency: Correcting dysfunctional mononuclear phagocyte disorders
por: Lazarus, Hillard M., et al.
Publicado: (2023) -
GM-CSF Inhibits c-Kit and SCF Expression by Bone Marrow-Derived Dendritic Cells
por: Barroeta Seijas, Amairelys Belen, et al.
Publicado: (2017) -
GM-CSF-Dependent Inflammatory Pathways
por: Hamilton, John A.
Publicado: (2019)